Aug 16, 2025

PGxAI Named a Key Player in Straits Research’s Pharmacogenomics (PGX) Market Report

Media Recognition | Published: Aug 16, 2025

news image

PALO ALTO, Calif., Sep. 22, 2025 — PGxAI has been recognized by Straits Research in its latest Pharmacogenomics (PGX) Market Size, Share & Trends Analysis Report (2025–2033), where the company is listed among the key market players and profiled as an emerging innovator in AI‑driven pharmacogenomics.

According to the report, the global pharmacogenomics market was valued at $6.13B in 2024 and is projected to reach $11.17B by 2033 at a 6.6% CAGR—underscoring accelerating adoption of AI, bioinformatics, and EHR‑integrated decision support across clinical workflows.

“We’re honored to be included by Straits Research as part of the industry’s leading cohort,” said Dr. Mike Zack, co‑founder and CEO of PGxAI. “This recognition reflects our focus on turning complex genomic and clinical evidence into precise, point‑of‑care recommendations that help clinicians reduce adverse drug reactions and improve outcomes.”

Straits Research highlights the growing role of AI/ML‑enabled platforms in scaling pharmacogenomic insights and improving turnaround time for guideline‑concordant prescribing—areas central to PGxAI’s product roadmap and health‑system integrations.

About PGxAI PGxAI is an AI‑driven precision‑medicine company that transforms multi‑omics and clinical data into real‑time, gene‑guided prescribing support for health systems, payors, and life sciences partners.

Success Stories
Serving Every Stakeholder in Healthcare
image
News
Oct 1, 2025
PGxAI Welcomes Roni Zeiger as Product Strategy Advisor
image
News
Sep 18, 2025
PGxAI Admitted to Creative Destruction Lab (CDL) Seattle — Computational Health 2025–2026
image
News
Sep 3, 2025
PGxAI Welcomes John Quackenbush as Scientific Advisor
image
Press Release
Aug 19, 2025
PGxAI and Sequencing.com Announce Strategic Partnership to Advance Affordable Pharmacogenomics
image
News
Aug 16, 2025
PGxAI Named a Key Player in Straits Research’s Pharmacogenomics (PGX) Market Report
image
News
Aug 3, 2025
PGxAI Welcomes David Blumenthal as Scientific Advisor
image
News
Jul 18, 2025
Benchmarking LLMs for Pharmacogenomic (PGx) Recommendations
image
News
July 04, 2025
AI & Multi-Omics in Pharmacogenomics: PGxAI’s New Review
image
Press Release
Jun 27, 2025
PGxAI Unveils Betelgeuse — New AI Model for Real-Time Clinical Outcome Analysis and Adaptive Recommendations
image
News
Jun 14, 2025
Upload Your Own Genetic Data: Instant Drug-Sensitivity Insights Now in All Base Models
image
News
May 16, 2025
Drug-Drug Interaction Module—FDA-Label Powered, Terminal-Ready—Now Live in All Open Models
image
News
Apr 23, 2025
PGxAI Unveils AI-Driven Genetic Tool to Personalize GLP-1 Drugs Including Ozempic®
image
News
Apr 15, 2025
PGxAI Debuts Deneb, an AI Model Revolutionizing Drug Development for Biopharma
image
News
Mar 16, 2025
Automated Phenoconversion Arrives: Real-Time, Context-Aware Drug-Response Scoring in Every Base Model
image
News
Feb 28, 2025
PGxAI Debuts Vega, an AI Model Set to Disrupt Precision Medicine
image
Press Release
Dec 24, 2024
Revolutionizing Precision Medicine: PGxAI Raises $1.5 Million in Funding for AI-Powered Pharmacogenetics Platform
image
News
Dec 21, 2024
The Ventures Award: The World's Premier Stage for Startup Excellence
image
Press Release
Dec 19, 2024
PGxAI Launches Sirius, an AI‑Powered Pharmacogenetics Model
image
Press Release
Jun 25, 2024
IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration